United States · FDA National Drug Code directory
ATORVALIQ
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46287-030_fb92775a-6d6d-4d62-ab23-045f16ec5895
- Product NDC
- 46287-030
- Form
- SUSPENSION
- Composition / generic term
- ATORVALIQ
- Labeler
- CMP Pharma, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230301
- Source listing expiry
- 20261231
Source-listed ingredients
- ATORVASTATIN CALCIUM TRIHYDRATE — 20 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 150 mL in 1 BOTTLE (46287-030-01) · 46287-030-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →